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 OBJECTIVES:  Celiac disease (CD)-associated duodenal dysbiosis has not yet been clearly deﬁ ned, and the 
mechanisms by which CD-associated dysbiosis could concur to CD development or exacerbation are 
unknown. In this study, we analyzed the duodenal microbiome of CD patients.
 METHODS:  The microbiome was evaluated in duodenal biopsy samples of 20 adult patients with active CD, 6 CD 
patients on a gluten-free diet, and 15 controls by DNA sequencing of 16S ribosomal RNA libraries. 
Bacterial species were cultured, isolated and identiﬁ ed by mass spectrometry. Isolated bacterial 
species were used to infect CaCo-2 cells, and to stimulate normal duodenal explants and cultured 
human and murine dendritic cells (DCs). Inﬂ ammatory markers and cytokines were evaluated by 
immunoﬂ uorescence and ELISA, respectively.
 RESULTS:  Proteobacteria was the most abundant and Firmicutes and Actinobacteria the least abundant phyla 
in the microbiome proﬁ les of active CD patients. Members of the  Neisseria genus (Betaproteobacteria 
class) were signiﬁ cantly more abundant in active CD patients than in the other two groups 
( P =0.03).  Neisseria ﬂ avescens (CD- Nf ) was the most abundant  Neisseria species in active CD 
duodenum. Whole-genome sequencing of CD- Nf and control- Nf showed genetic diversity of the iron 
acquisition systems and of some hemoglobin-related genes. CD- Nf was able to escape the lysosomal 
compartment in CaCo-2 cells and to induce an inﬂ ammatory response in DCs and in  ex-vivo mucosal 
explants.
 CONCLUSIONS:  Marked dysbiosis and an abundance of a peculiar CD- Nf strain characterize the duodenal microbiome 
in active CD patients thus suggesting that the CD-associated microbiota could contribute to the many 
inﬂ ammatory signals in this disorder.
 SUPPLEMENTARY MATERIAL is linked to the online version of the paper at  http://www.nature.com/ajg 
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 INTRODUCTION
 Celiac disease (CD) is an autoimmune, infl ammatory disorder 
of the small intestine that involves interactions between genetic 
and environmental factors ( 1 ). In genetically susceptible individu-
als (human leukocyte antigen (HLA)-DQ2/DQ8 carriers), inges-
tion of gluten leads to an abnormal intestinal immune response 
involving both the adaptive and the innate immunity, which is 
characterized by a failure to establish and/or maintain tolerance 
to dietary peptides present in wheat, barley, and rye (particularly 
wheat gliadin) ( 2 ) and by intestinal damage ( 3 ). Subsequent stud-
ies challenged the gluten-hypersensitivity dogma and suggested 
that exposure to gluten may not be the only trigger of CD ( 4,5 ). 
In the case of gluten exposure, it remains a mystery why: (i) the 
frequency of DQ2/DQ8 molecules in the general population is 
about 30%, but only 1−3% of individuals develop CD ( 1 ); (ii) CD is 
increasingly being diagnosed in adulthood, many years aft er intro-
duction of gluten in the diet ( 6 ); and (iii) the prevalence of CD 
is rapidly increasing in the western world (although consumption 
of gliadin-containing food has not increased) ( 7 ). In this context, 
other environmental factors such as the intestinal ecosystem have 
been implicated in the pathogenesis of CD ( 8,9 ). Th e rationale for 
this concept is that the gut microbiota is involved in the follow-
ing: (i) diff erentiation of the intestinal epithelium; (ii) regulation 
of gut permeability and immunity; (iii) development of adequate 
responses to microbial and dietary antigens; and (iv) avoidance of 
overreactions ( 8,10–12 ). Consequently, there is growing interest in 
understanding whether interactions between intestinal microbes 
and innate immunity of the host could infl uence CD expression 
by promoting infl ammation and/or impairing mucosal function.
 Th e present study was prompted by our previous fi nding of 
increased proliferation and decreased diff erentiation of intesti-
nal cells toward the secretory goblet cell lineage in children with 
active CD and in children on a gluten-free diet (GFD) with respect 
to controls ( 13 ). Notably, maintenance of a correct number of 
functional goblet cells is required for homeostasis of the intesti-
nal mucosal environment, and defi ciencies in mucin composition 
render the mucosa more susceptible to damaging agents (e.g., 
bacterial infections) in the lumen ( 14 ). In line with these observa-
tions, studies conducted on fecal samples revealed the diff erences 
between CD patients and healthy controls in terms of microbiota 
composition and related metabolites ( 8,9,15–17 ), whereas data 
about the mucosa-associated microbiota are inconclusive, mainly 
because they focused on specifi c groups of bacteria, used diff erent 
methodologies and specimens, or investigated heterogeneous CD 
populations in terms of age, clinical conditions, and medications 
( 18–25 ). Th anks to the advent of next-generation sequencing, we 
can now study simultaneously all the genomes of a microbial com-
munity directly recovered from specifi c environments ( 26–29 ). 
Th is technique can also reveal changes in the gut microbiome pro-
fi le before and aft er therapy ( 25,30 ).
 Th e aim of this study was to use 16S ribosomal RNA (rRNA) 
metagenomics to determine the CD-associated duodenal dysbio-
sis in adult celiac patients and elucidate the mechanisms by which 
gut CD-associated dysbiosis could concur to CD development or 
exacerbation.
 METHODS
 Patients and samples
 In this cohort study, 41 unrelated Caucasian individuals were 
recruited, over 2 years, from among patients attending the Depart-
ments of Gastroenterology of the Universities of Salerno and 
of Roma-Tor Vergata, Italy. Subjects were enrolled from among 
patients with symptoms suggestive of CD, from among patients 
with a diagnosis of gastroesophageal refl ux disease (GERD), and 
from among GFD CD patients undergoing CD follow-up, all of 
whom consented to participate in the study. Th e exclusion crite-
ria for enrollment were any known food intolerance apart from 
gluten, IgA defi ciency, treatment with antibiotics, proton pump 
inhibitors, antiviral or corticosteroids, or assumption of probiot-
ics in the 2 months before sampling. Twenty patients with active 
CD were on a gluten-containing diet. Th ese patients were positive 
for CD-specifi c antibodies (IgA anti-endomysium (EMA) and/or 
IgA anti-tissue transglutaminase 2 (TG2)) and had villous atrophy 
on histological examination ( 31 ). Six patients had been on a GFD 
for at least 2 years, were EMA and anti-TG2 negative, and none of 
them had villous atrophy on histological examination. HLA-DQ2 
and/or –DQ8 molecules were present in 100% of CD and GFD 
patients. Th e control group was constituted by seven patients 
with irritable bowel syndrome and/or dyspepsia, fi ve patients with 
GERD, two patients with chronic gastritis, and one patient with 
iron loss caused by a fi bromatous uterus.
 We collected blood samples (to obtain DNA and serum) and 
duodenal biopsies, under sterile conditions to avoid contami-
nation, from all enrolled individuals. Biopsies not used for his-
tological examination were immediately cooled in dry ice and 
stored at −80 °C until genetic analysis, and/or stored in a trans-
port medium for microbiological assays, and/or immediately 
cultured for  in vitro experiments. Th e study was approved by 
the University of Naples Federico II Ethics Committee (Prot. N. 
36/13). Clinical and laboratory features of the 3 study groups are 
shown in  Table 1 .
 DNA extraction and 16S rRNA sequencing
 Total DNA was extracted from duodenal biopsies (3 mg/sample) 
using the QIAamp DNA Mini Kit (Qiagen,Venlo, Th e Netherlands) 
according to the manufacturer’s instructions. A 548 bp ampli-
con, spanning from V4 to V6 variable regions of the 16S  rRNA 
gene, was amplifi ed using modifi ed fusion primers ( Supplemen-
tary Table S1 and  Supplementary Material online) ( 32 ). Next-
generation sequencing reactions were carried out on a 454 
Genome Sequencer instrument (Roche, Penzberg, Germany) 
according to the manufacturer’s instructions ( 33 ). Sequences 
were obtained in all enrolled subjects and analyzed using QIIME 
v. 1.9.1 ( Supplementary Material ) ( 34 ).
 Microbiological analysis
 Culture-dependent microbiological analysis and isolation of aer-
obic bacterial species (both adherent and intracellular microbial 
fl ora) were performed in individuals (9/20 active CD patients and 
8/15 controls) for whom duodenal biopsies were available. In this 
study, we did not consider anaerobic species. Bacterial species 
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were identifi ed by mass spectrometry using the Matrix Assisted 
Laser Desorption/Ionization (MALDI) mass spectrometer 
(Bruker Daltonics MALDI Biotyper, Fremont, CA;  Supplemen-
tary Material ). We also cultured and isolated aerobic bacterial 
species from the oropharynx of 2 control subjects.
 Neisseria ﬂ avescens whole-genome sequencing
 Genomic DNA from  Neisseria fl avescens ( Nf)- isolated strains was 
prepared as previously reported ( 35 ). Th eir whole-genome shot-
gun sequencing was carried out using the Genome Sequencer 
FLX System (454 Life Sciences and Roche, Basel, Switzerland), as 
previously described ( Supplementary Material ) ( 36 ). Sequenc-
ing reads were subjected to quality trimming, error correction, 
and assembly using the SPAdes soft ware ( 37 ); default parameters 
and genome annotation were performed with the RAST Genome 
Annotation Server ( 38 ). Custom scripts were used to automate 
and parse the results of all-against-all tBlastx searches (incorpo-
rating 23 representative  Neisseria genomes) and to identify clus-
ters of orthologous genes ( COGs ).
 Phylogenetic analyses
 Th e sequences of 904 unambiguous orthologous single copy genes 
present in all the considered  Neisseria genomes were aligned at 
the amino acid level using the muscle soft ware ( 39 ), and align-
ments were subjected to exclusion of low-quality regions using 
the GBlocks soft ware ( 40 ), before concatenation to leave 93,642 
amino acid positions. Maximum likelihood bootstrap phylo-
genetic analysis of protein sequences was performed using the 
RAxML soft ware ( 41 ) with invariable and 4 variable gamma-
distributed site rate categories under the WAG amino acid substi-
tution model ( 42 ).
 Iron acquisition systems: Genetic and phenotypic 
characterization
 Th e coding regions of the hemoglobin receptor ( hmbR) gene, of 
the haptoglobin-hemoglobin ( hpuA/B ), and transferrin ( tbpA/B )-
binding protein genes, all involved in iron uptake from diff erent 
sources, were amplifi ed from the genomic DNA of the isolated 
 Nf strains and sequenced by Sanger methods ( Supplementary 
Table S2 and  Supplementary Material ). Th e ability to utilize dif-
ferent iron sources was assessed by growing CD- Nf and control- Nf 
isolates on iron-restricted media supplemented with hemoglobin 
(Hb), transferrin, and ferric nitrate (FeN) nonahydrate impreg-
nated discs.  N. meningitidis ( Nm ) (MC58 serogroup B) was used 
as pathogenic control bacterium ( Supplementary Material ).
 Human and mouse dendritic cells and  ex vivo mucosal explants 
 in vitro experiments
 Splenic and bone marrow-derived dendritic cells (DCs) were iso-
lated from six C57BL/6 mice diluting 1 ml of a collagenase type 
IV solution (Sigma-Aldrich, St Lois, MO) in 9 mL RMPI IX and 
using a mechanical razor blade to disrupt the organs. Aft er tis-
sue disruption, red blood cells were lysed and CD11c + DCs were 
isolated using magnetic MicroBeads (Miltenyi Biotec, Cambridge, 
MA) according to the manufacturer’s instructions.
 Monocyte-derived DCs were derived from peripheral blood 
monocytes of three healthy volunteers. CD14 + monocytes were 
isolated from total peripheral blood mononuclear cells using 
magnetic MicroBeads (Miltenyi Biotec) according to the manu-
facturer’s instructions and cultured for 6 days in the presence of 
interleukin-4 (IL-4) and granulocyte macrophage colony-stimu-
lating factor (GM-CSF) as previously described ( 43 ).
 Both human and murine DCs were cultured in complete 
medium in the presence of 0.1 nM retinoic acid and 2 ng/ml trans-
forming grow factor-β , to mimic the small intestinal micro-envi-
ronment, as previously described ( 44 ). DCs were stimulated for 
48 h with 50 μ g/ml of fi ltered bacterial lysates ( Supplementary 
Materials and Methods ) from  Nf strains isolated from fi ve active 
CD patients ( Nf 1,2,3,7,8). Bacterial lipopolysaccharide (LPS; 
100ng/ml) was used as a positive control. In addition, for murine 
DCs, lysates from  Serratia marcescens ( Sm, Gammaproteobacte-
ria) isolated from a septic patient were used as pro-infl ammatory 
controls, whereas  Lactobacillus GG ( L GG, Bacilli) was used as a 
negative non-infl ammatory control as described previously ( 44 ). 
Forty-eight hours later, supernatants were harvested and tested 
 Table 1 .  Clinical and laboratory features of the three groups 
enrolled in the study 
  Group 
 Clinical features  Controls  Active CD 
patients 
 GFD patients 
 No. of subjects  15  20  6 
 Age in years 
(Mean±s.d.) 
 42±16  38±12  39±11 
 Sex F/M (%F)  13F/2M (85%)  18F/2M (89%)  5F/1M (83%) 
 Clinical data (%)    
 Anemia a  6/15 (40%)  9/20 (45%)  1/6 (17%) 
 Weight loss  1/15 (7%)  2/20 (10%)  0/6 (0%) 
 Diarrhea  1/15 (7%)  5/20 (25%)  2/6 (33%) 
  Dyspepsia 
and/or IBS 
 7/15 (47%)  10/20 (50%)  2/6 (33%) 
 Chronic gastritis  2/15 (13%)  0/20 (0%)  0/6 (0%) 
 GERD  5/15 (33%)  0/20 (0%)  0/6 (0%) 
 Presence of CD 
antibodies (EMA 
and/or TG2 IgA) 
 10(+), 5 b /15  20 (+)/20  0 (+)/6 
 Positive family 
history of CD (%) 
 1/15 (7%)  5/20 (25%)  1/6 (17%) 
 Duodenal biopsy 
(Marsh Index) (%) 
 15/15 M0 
(100%) 
 4/20 M3A (20%) 
 8/20 M3B (40%) 
 8/20 M3C (40%) 
 4/6 M0 (67%) 
 2 c /6 M1 (33%) 
 CD, celiac disease; EMA, antiendomysium IgA; F, female; GERD, gastroeso-
phageal reﬂ ux disease; GFD, gluten-free diet; IBS, irritable bowel syndrome; 
M, male; TG2, anti tissue-transglutaminase 2 IgA. 
 a Iron-deﬁ ciency anemia. 
 b Not assayed in GERD. 
 c Partial villous atrophy and intra-epithelial lymphocyte count =25/100. 
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by ELISA to check the levels of IL-12p40 (BD OptEIA, Becton 
Dickinson, Milano, Italia) and tumor necrosis factor-α (TNF-α ; 
eBioscience, San Diego, CA). All experiments were performed 
in duplicate. Mice were housed in the animal facility of the 
University of Chicago, Knapp Center for the Biomedical Discovery. 
All experiments were performed in accordance with the Institu-
tional Biosafety Committee and the Institutional Care and Use 
Committee.
 Duodenal fragments sampled from three control subjects were 
collected, oriented, and used for  in vitro challenge with CD- Nf to 
evaluate the infl ammatory properties of this bacterium. We chose to 
perform  ex-vivo challenge with CD- Nf on duodenal mucosa from 
controls and not from CD patients (active and treated) in order to 
evaluate whether the infl ammatory eff ect of the bacterium occurred 
regardless of other contributing factors likely present in CD patients. 
Mucosal explants were collected in ice-chilled tissue culture 
medium and cultured for 20 min. Fragments were placed on a stain-
less-steel mesh positioned over the central well of an organ-culture 
dish containing culture medium (37 °C), with the epithelium facing 
upward. One fragment per subject remained untreated and used as 
reference, whereas the other two fragments were treated with the 
CD- Nf by using two multiplicities of infection (MOI)—namely, 
1:10 and 1:50. Briefl y, fragments were cultured for 6 h, and incuba-
tion was stopped by washing, embedding tissues in optimal cutting 
temperature (OCT, Tissue TEK; Milews Laboratories, Elkhart, IN), 
and snap freezing them in cooled isopenthane. Samples and super-
natants were then stored in liquid nitrogen until analysis. Cryostat 
sections (5 μ m) of each sample were air dried and then processed. 
We performed immunofl uorescence analysis of cells positive for 
the induced markers of infl ammation HLA-DR (the major histo-
compatibility complex class II molecules) and COX-2 (enzyme 
rapidly induced by pro-infl ammatory signals in monocytes or mac-
rophages) ( Supplementary Material ). Using ELISA, we also evalu-
ated the levels of interferon-γ , TNF-α , IL-6, IL-23, IL-17A, IL-17F, 
and IL-12p70 (Procarta Plex multiplex immunoassay; eBioscience) 
in supernatants of untreated and treated mucosal fragments accord-
ing to the manufacturer’s instructions. All experiments were per-
formed in duplicate.
 Internalization and intracellular localization of  N. ﬂ avescens in 
epithelial cells
 CaCo-2 epithelial cells were obtained from a Bank of Human and 
Animal Continuous Cell Lines (CEINGE-Biotecnologie Avanzate, 
S.C.a R.L. Naples, Italy). Th e cells were grown in Eagle’s mini-
mal essential medium (Sigma-Aldrich) and supplemented with 
10% fetal bovine serum (Lonza, Basel, Switzerland), 1% l-glut-
amine (Sigma-Aldrich), and 1% non essential amino acids in the 
presence of penicillin (50 U/ml) and streptomycin (50 μ g/ml). 
To distinguish between extracellular and intracellular bacte-
ria,  Nf internalization was evaluated by adapting the infection 
protocol to the immunofl uorescence analysis ( Supplementary 
Material ) ( 45,46 ). Specimens were viewed with the Leica TCS 
SP5 confocal laser-scanning microscope equipped with a 63x 
oil immersion objective. Images were processed using Adobe 
Photoshop CS5.
 Statistical analysis
 Diff erences in abundance of specifi c taxa across the study groups 
were identifi ed with analysis of variance together with a Bon-
ferroni correction within QIIME. Diff erences in Operational 
taxonomic units with  P ≤0.05 aft er Bonferroni adjustment were 
considered statistically signifi cant. To compare the alpha diver-
sity across sample groups, a non-parametric two sample  t -test 
was run using 999 Monte Carlo permutations. Non-parametric 
multivariate analysis of variance (ADONIS) ( 47 ) using Unifrac 
distance matrices was used to test the signifi cance of diff erences 
in beta diversity. Th e mean fold change value (untreated/treated) 
and the s.e.m. were calculated for each investigated cytokine in 
supernatants of  ex vivo mucosal explants. Between-group com-
parisons were tested by the Friedman test for paired data with 
Bonferroni correction and the diff erences considered signifi cant 
at a  P- level  < 0.05. A two-way analysis of variance test was used to 
compare means between diff erent groups of human and murine 
DCs treated with diff erent bacterial lysates.
 RESULTS
 Microbiome proﬁ les
 Sample metadata obtained from 16S bacterial rRNA sequencing 
of duodenal samples from all enrolled subjects are summarized 
in  Supplementary Table 3 . Twenty distinct phyla were identifi ed 
( Supplementary Figure S1 ), of which Proteobacteria, Actinobac-
teria, Bacteroidetes, Firmicutes, and Fusobacteria were the only 
ones present at a relative abundance >1%. Proteobacteria was the 
most abundant phylum in the three study groups, whereas the 
Actinobacteria and Firmicutes phyla were less abundant in the 
microbiome profi les of active CD patients than in the other two 
groups ( Figure 1a ). Class, order, family, and genus in each phy-
lum were also identifi ed ( Figures 1b–e ). Th ere were no signifi cant 
diff erences between the three groups within the Firmicutes phy-
lum. Within the Proteobacteria phylum, the Betaproteobacteria 
class was highly represented in the gut microbiome of active CD 
patients, although its levels did not directly correlate with dis-
ease severity. In addition, within the Betaproteobacteria class, the 
Neisseriales order ( P =0.009), the  Neisseriaceae family ( P =0.01), and 
the  Neisseria genus ( P =0.03) were signifi cantly more abundant in 
active CD patients than in the other 2 study groups, and the  Neis-
seria genus was the most abundant genus (99.8%) within the  Neis-
seriaceae family ( P <0.05) ( Figure 1e ). Th e Gammaproteobacteria 
class was less abundant in active CD patients than in the other two 
study groups ( Figure 1b ), whereas the  Acinetobacter genus was 
more abundant in GFD patients and controls than in active CD 
patients, although the diff erence was not signifi cant ( Figure 1e ).
 Alpha rarefaction curves (obtained with the QIIME pipeline, 
 Supplementary Material ) showed that bacterial community rich-
ness did not diff er between CD patients and controls ( Figure 2a ). 
Th e Beta diversity of bacterial communities was statistically signifi -
cant within the three groups computed with both the unweighted 
( P =0.017,  R 2 =0.06; ADONIS) and the weighted Unifrac ( P =0.014, 
 R 2 =0.10; ADONIS) method ( Figures 2b, c ). Th is analysis suggests 
that active and GFD CD microbiomes are more similar to each other 
Ofﬁ cial journal of the American College of Gastroenterology The American Journal of GASTROENTEROLOGY
883
C
O
LO
N
/S
M
A
LL
 B
O
W
E
L
Duodenal Dysbiosis in Adult CD Patients
60.0%
Controls
CD patients
GFD patients
Phylum
50.0%
40.0%
30.0%
R
el
at
iv
e 
ab
un
da
nc
e 
(%
)
R
el
at
iv
e 
ab
un
da
nc
e 
(%
)
R
el
at
iv
e 
ab
un
da
nc
e 
(%
)
R
el
at
iv
e 
ab
un
da
nc
e 
(%
)
20.0%
10.0%
0.0%
30.00%
35.00%
25.00%
15.00%
5.00%
20.00%
10.00%
0.00%
*
*
*
30.0%
35.0%
25.0%
15.0%
5.0%
20.0%
10.0%
0.0%
30.0%
35.0%
25.0%
15.0%
5.0%
20.0%
10.0%
0.0%
Ac
tin
ob
ac
ter
ia
Ba
cte
roi
de
tes
Fir
mi
cu
tes
Fu
so
ba
cte
ria
Pro
teo
ba
cte
ria
FamilyOrder
Genus
Ac
tin
ob
ac
ter
ia
Pr
op
ion
iba
cte
ria
ce
ae
Po
rph
yro
mo
na
da
ce
ae
Pr
op
ion
iba
cte
riu
m
(Ac
tino
bac
teri
a)
Po
rph
yro
mo
na
s
(Ba
cte
roid
ete
s)
Pr
ev
ote
lla
 
(Ba
cte
roid
ete
s,
Pr
ev
ote
lla
ce
ae
)
(Pr
evo
tella
) (B
act
ero
ide
tes
,
Pa
rap
rev
ote
llac
ea
e)
Str
ep
toc
oc
cu
s
(Fir
mic
ute
s)
Fu
so
ba
cte
riu
m
(Fu
sob
act
eria
)
Ne
iss
eri
a
(Pr
ote
oba
cte
ria)
Ac
tin
ob
ac
illu
s
(Pr
ote
oba
cte
ria)
Ha
em
op
hilu
s
(Pr
ote
oba
cte
ria)
Ac
ine
tob
ac
ter
(Pr
ote
oba
cte
ria)
Ac
tin
om
yce
tal
es
Ba
cte
roi
da
les
La
cto
ba
cill
ale
s
Fu
so
ba
cte
ria
les
Ne
iss
eri
ale
s
Pa
ste
ure
lla
les
Ps
eu
do
mo
na
da
les
Pr
ev
ote
lla
ce
ae
Pa
rap
rev
ote
llac
ea
e
Str
ep
toc
oc
ca
ce
ae
Fu
so
ba
cte
ria
ce
ae
Ne
iss
eri
ac
ea
e
Pa
ste
ure
lla
ce
ae
Mo
rax
ell
ac
ea
e
Ba
cte
roi
dia
Ba
cill
i
Fu
so
ba
cte
riia
Be
tap
rot
eo
ba
cte
ria
Ga
mm
ap
rot
eo
ba
cte
ria
R
el
at
iv
e 
ab
un
da
nc
e 
(%
)
40.0%
30.0%
35.0%
25.0%
15.0%
5.0%
20.0%
10.0%
0.0%
Class
Controls
CD patients
GFD patients
Controls
CD patients
GFD patients
Controls
CD patients
GFD patients
Controls
CD patients
GFD patients
 Figure 1 .  Duodenal microbiome taxonomic composition in controls, in active and in gluten-free diet (GFD) celiac disease (CD) patients. ( a ) Relative abun-
dance at phylum level. Proteobacteria was the most abundant phylum in all 3 groups with an average abundance of 39.3%. ( b ) Class level classiﬁ cation in 
the 3 groups showed a decreasing trend for the Betaproteobacteria class in GFD patients (4%) and controls (10%) versus CD patients (26%). The Gamma-
proteobacteria class was less abundant in CD patients (21%) than in controls (28%) and GFD patients (30%). ( c ) Order level classiﬁ cation revealed 
a signiﬁ cant difference ( P =0.009) in the  Neisseriales order among controls (~10%), GFD patients (~4%), and CD patients (~26%). ( d ) Also at family level, 
the  Neisseriaceae family was signiﬁ cantly less abundant ( P =0.01) in controls (~10%) and GFD patients (4%) than in CD patients (~32%). ( e ) At genus 
level,  Neisseria was signiﬁ cantly more abundant ( P =0.03) in active CD patients (26%) than in controls (10%) and GFD patients (4%). Taxa 
(in parentheses) refer to the phylum to which the genus belongs. The data reported are ﬁ ltered by a frequency higher than 1%. Error bars indicate 
standard error. Asterisks refer to taxa that differed signiﬁ cantly among the three groups ( P <0.05, analysis of variance).
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than control microbiomes are to the active or GFD CD microbiomes. 
Th is fi nding is supported by the tighter clustering of active and GFD 
CD points compared with control points (see  Figures 2b, c ). Th e 
high heterogeneity of the volunteers in the control group (which was 
inevitable given the diffi  culty in collecting biopsy samples) caused a 
slight variability in the microbiome composition, although no signifi -
cant diff erences were observed within the control group in terms 
of the presence/absence of dyspepsia or irritable bowel syndrome 
( Figure 2b, c ,  Supplementary Figure S1 and  Supplementary Tables 
S4 and S5 ). Furthermore, we did not fi nd any correlation between 
the diff erences in intestinal microbiome composition and the histo-
logical features among the controls enrolled in the study.
 Microbiological assays
 To verify the viability of the aerobic species identifi ed by 16S 
sequencing, which include  Neisseria , we performed standard micro-
biological cultures of duodenal biopsy specimens. Diff erential anal-
ysis (diff erential culture media and mass spectrometry analysis) 
revealed a cultivable aerobic biodiversity in duodenal microfl ora of 
the samples tested ( Supplementary Table S6 ). In particular, nei-
ther  Lactobacillus nor  Bacillus cereus (which belong to Firmicutes) 
was found in the microbiome of the active CD patients, although 
both are commensal bacteria in the healthy gut. In contrast,  Nf was 
viable in all duodenal mucosa samples from active CD patients 
(CD- Nf ), with a MALDI-TOF score above 2 (data not shown), but 
was undetectable in the duodenal mucosa samples from controls 
( Figure 2d ). However, we were able to culture and isolate  Nf from 
the oropharynx of two control subjects (control- Nf ), in whom this 
bacterium is commensal (data not shown).
 Genotypic and phenotypic features of the isolated CD- Neisseria 
ﬂ avescens 
 Nfs isolated from three active CD patients (namely CD- Nf 1, 
CD- Nf 2, and CD- Nf 3), whose mucosal intestinal biopsies were 
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 Figure 2 .  Alpha rarefaction curves and beta diversity analysis in controls, in active and in gluten-free diet (GFD) celiac disease (CD) patients. ( a ) Alpha 
rare faction curves at normalization by depth of 792 sequences per sample (obtained with the QIIME pipeline,  Supplementary Materials and Methods ) 
showed that bacterial community richness did not differ between CD patients and controls. ( b ) Principal-coordinates analysis applied to the unweighted 
and ( c ) weighted UniFrac distances shows a difference between CD patients and controls. In fact, both active CD and GFD patients are distinct from 
controls, which moreover had a random distribution ( P =0.017,  R 2 =0.06; ADONIS and  P =0.014,  R 2 =0.10; ADONIS, respectively). Filled blue squares refer 
to a subgroup of control subjects affected by gastroesophageal reﬂ ux disease, chronic gastritis, or ﬁ bromatous uterus, whereas opened blue squares refer 
to a subgroup of controls affected by dyspepsia or irritable bowel syndrome; both these control groups are CD negative. ( d ) This ﬁ gure shows the viability of 
 N. ﬂ avescens species (arrows) in duodenal mucosa cultures from active CD patients (top panel), whereas the bacterium did not grow in duodenal cultures 
from control subjects (bottom panel). 
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monocyte-derived ( Figure 4c ) DCs challenged for 48 h with bac-
terial lysates obtained from CD- Nf1 , CD- Nf 2, CD- Nf 3, CD- Nf 7, 
and CD- Nf 8 ( Figures 4b, d and e ). DCs were cultured in the pres-
ence of retinoic acid and transforming growth factor-β , both of 
which are abundant in the small intestinal microenvironment, to 
mimic physiological intestinal conditions. Aft er 48 h of stimula-
tion, the level of IL-12p40, a cytokine produced by DCs under 
infl ammatory conditions, was higher in murine splenic DCs 
treated with CD- Nf strains than in untreated DCs (untreated vs. 
 Nf 1  P =0.0021, vs.  Nf 2  P =0.0003, vs.  Nf 3  P =0.0031) ( Figures 4a 
and b ) and in murine splenic DCs challenged with  L GG ( L GG vs. 
 Nf 1  P =0.01, vs.  Nf 2  P =0.0016, vs.  Nf 3  P =0.0161), a bacterium that 
colonizes the gut of healthy subjects and that in normal concentra-
tions does not exert an infl ammatory eff ect ( Figure 4b ). Levels of 
IL-12p40 were also higher in supernatants of DCs treated with the 
three strains of CD- Nf than in DC supernatants aft er stimulation 
with bacterial LPS (LPS vs.  Nf 1  P =0.0339, vs.  Nf 2  P =0.0047, vs. 
 Nf 3  P =0.05) and comparable to or even higher than (as assessed 
for  Nf 2 ( P =0.01) those detected upon challenge with lysates of 
 Sm (Gammaproteobacteria), a bacterium isolated from patients 
aff ected by sepsis and known to exert pro-infl ammatory eff ects 
on DCs ( Figure 4b ) ( 51 ). Th e results of this set of experiments 
indicate that each of the 3 strains isolated from the small intestinal 
mucosa of CD patients was able to imprint a pro-infl ammatory 
phenotype on murine splenic DCs  in vitro .
 We confi rmed these results in bone marrow-derived murine 
CD11c + DCs (data not shown). Furthermore, we tested the pro-
infl ammatory properties of the lysates of  Nf strains isolated from 
active CD subjects on human monocyte-derived DCs ( Figure 4c ) 
and found that the production of both TNF-α ( Figure 4d ) and 
IL12p40 ( Figure 4e ) was higher in  Nf -stimulated DCs than in 
either untreated or LPS-treated DCs ( P <0.0001, one-way analysis 
of variance and multiple comparison analysis with Bonferroni cor-
rection). Th is fi nding suggests that  Nf strains exert a pro-infl am-
matory eff ect on human monocyte-derived DCs. Of note, the 
 Nf10 strain isolated from a pharyngeal swab of a control subject 
enhanced the production of the pro-infl ammatory cytokines TNF-
α when cultured in conditions mimicking the small intestinal 
environment (medium containing retinoic acid and transforming 
growth factor-β). Th is may suggest that not only the presence of a 
specifi c bacterial strain but also particularly the specifi c microen-
vironment and milieu may determine which eff ect is exerted on 
immune cells.
 To verify the infl ammatory  in vitro eff ect of CD- Nf , we exposed 
 ex-vivo mucosal explants from control subjects to CD- Nf bacteria 
for up to 6 h, and using immunofl uorescence we found increased 
epithelial expression of the infl ammation markers HLA-DR and 
COX-2. In particular, HLA-DR expression ( Supplementary 
Figure S3 ) was enhanced in villus enterocytes, in the basal cyto-
plasmatic compartment, as well as on the brush border and baso-
lateral membranes. HLA-DR was overexpressed also in the lamina 
propria, particularly near the surface epithelium. In addition, in 
experiments with COX-2 (data not shown), the mean number of 
COX-2-positive epithelial cells increased from 16/100 (untreated 
mucosa) up to 25/100 aft er CD- Nf challenge.
available, and from the oropharynx of one healthy individual 
(control- Nf ) were subjected to whole-genome shotgun sequencing 
as reported in the Methods section. Genome assembly and anno-
tation were performed using standard approaches ( 37,38 ) and 
resulted in assemblies ranging in size from 2.22 to 2.30 Mb ( Sup-
plementary Table S7 ). Phylogenetic analyses of the tested  Nf 
genomes confi rmed the close phylogenetic relationships between 
all the strains recovered in the current study and those annotated in 
GenBank ( http://www.ncbi.nlm.nih.gov/genome/genomes ), namely, 
the  N. fl avescens strains SK114 and NRL 30031,  N. mucosa strain 
C102, and  N. subfl ava strain NJ9703 ( Supplementary Figure S2 ).
 We used reciprocal best blast analyses to identify genes present 
in all CD- Nf genomes, but absent in at least one of the other stud-
ied  Nf genomes (see above), and in control- Nf . Notably, the isolates 
from our control- Nf and the two commensal  Nf genomes (SK114 
and NRL 30031) annotated in GenBank possess neisserial hapto-
globin-hemoglobin A/B ( hpuA/B ) and transferrin A/B ( tbpA/B ) 
binding protein genes but lack the  hmbR gene. On the contrary, all 
isolates from active CD patients (CD- Nf 1, CD- Nf 2, and CD- Nf 3) 
lack the  hpuA/B and  tbpA/B genes but possess the  hmbR gene (data 
not shown). Th is result was confi rmed by PCR analysis in 5 CD- Nf 
samples ( Supplementary Table S8 ). Th e  hmbR gene encodes a Hb 
receptor that has more frequently been associated with disease iso-
lates of  N. meningitidis ( Nm ) than with carriage isolates, suggesting 
that this receptor contributes to  Nm -related disease ( 48–50 ). As the 
process of iron scavenging from the host is an important virulence 
attribute of bacterial pathogens, we evaluated the ability of  Nf iso-
lated from the duodenal mucosa of CD patients to scavenge iron 
from Hb and from other sources compared with control- Nf . We 
observed that, on Mueller-Hinton (MH) agar plus desferal, strains 
isolated from CD patients (CD- Nf 1, CD- Nf 2, CD- Nf 3, CD- Nf 7, 
and CD- Nf 8) and  Nm (pathogenic positive control) grew well 
with Hb as the sole iron source, which indicates that these strains 
express at least one Hb receptor, in agreement with our sequence 
data. In contrast, the control- Nf strain grew well also using trans-
ferrin as an iron source, which indicates that this strain utilizes 
iron through the  hpuA/B and  tbpA/B gene systems— a fi nding that 
is in accordance with our control- Nf genomic sequence and PCR 
results ( Supplementary Table 8 ).
 Internalization of  N. ﬂ avescens in epithelial cells
 To evaluate how CD- Nf and control- Nf are internalized in the host 
epithelial cells, we infected CaCo-2 epithelial cells with  Nf from 
two active CD patients (CD- Nf 1 and CD- Nf 7) and used confocal 
microscopy to compare their intracellular localization with that 
of control- Nf up to 6 h aft er infection ( Figure 3 ). At the end of the 
experiment, although CD- Nfs (CD- Nf 1and CD- Nf 7) were inter-
nalized (red signals) and seldom colocalized with the marker of 
the late/endosome-lysosomal pathway (LAMP-1, green signals), 
control- Nf (CTR- Nf 10) clearly colocalized with LAMP1, indicat-
ing that most CD- Nfs escape this intracellular compartment.
 In vitro inﬂ ammation effect of CD- Nf 
 We investigated the pro-infl ammatory properties of CD- Nf bac-
terial strains  in vitro using both murine ( Figure 4a ) and human 
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 CD- Nf also promoted the release of infl ammatory cytokines 
(interferon-γ , TNF-α , IL-6, IL-23, IL-17A, IL-17F, and IL-12p70). 
In fact, the levels of these cytokines were higher in the super-
natants of treated than in untreated biopsies as assessed in 
organ-culture experiments ( Table 2 ), and the increase was signi-
fi cant for interferon-γ ( P =0.001), TNF-α ( P <0.011), and IL-23 
( P =0.015). We show that IL-12p70 and IL-23 share the subunit 
IL-12p40 thus suggesting that there might be an increase in 
IL-12p40 subunit production.
 DISCUSSION
 CD-associated duodenal dysbiosis is not yet clearly defi ned, and 
the mechanisms by which gut CD-associated dysbiosis could 
concur to CD development or exacerbation remain largely 
unknown. In the attempt to shed light on this issue, we used 
16S rRNA metagenomics to determine whether the duodenum 
microbiome diff ered among three groups of adult individuals: 
active CD patients, GFD CD patients, and controls.
 Of the fi ve major phyla present with a frequency above 1% in 
the gut microbiome of our three study groups (Proteobacteria, 
Actinobacteria, Bacteroidetes, Firmicutes, and Fusobacteria), 
members of the phylum Proteobacteria were more abundant and 
those of the Firmicutes and Actinobacteria phyla less abundant in 
active CD than in either GFD patients or controls. A similar dys-
biosis was previously reported in the gut microbiome of four adult 
CD patients with gastrointestinal symptoms studied by 16S rRNA 
gene sequencing ( 23 ). Th e same group of investigators confi rmed 
this dysbiosis in the gut microbiome of 17 GFD CD patients with 
persistent symptoms but not in 17 asymptomatic GFD patients 
( 52 ). Similar results were obtained in biopsy specimens from active 
CD children when compared with GFD and control children ( 25 ). 
All the above data support the concept that the gut dysbiosis asso-
ciated with the active stage of CD is characterized by an increase 
in Proteobacteria and a decrease in Firmicutes phyla. However, no 
other group has previously explored how specifi c bacterial species 
detected in the duodenal mucosa of CD patients could contribute 
to the CD-associated gut malfunction.
 Within the bacterial genera detected in the gut microbiome 
of the 3 study groups by 16S rRNA gene sequencing, the relative 
abundance of the  Neisseria genus was signifi cantly higher ( P =0.03) 
in active CD patients (26%), than in either GFD patients (4%) or 
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 Figure 3 .  N. ﬂ avescens internalization in epithelial cells.  N. ﬂ avescens isolated from the gut mucosa of active celiac disease (CD) patients (CD- Nf ) seldom 
colocalized with lysosomes (LAMP-1) in CaCo-2 cells, whereas  N. ﬂ avescens isolated from the oropharynx of control subjects (CTR- Nf ) clearly colocalized 
with LAMP-1. The ﬁ gure (which is representative of three independent experiments) shows the results obtained 6 h after infection of CaCo-2 cells with 
 N. ﬂ avescens (multiplicity of infection 1:50) isolated from 2 active CD patients (CD- Nf 1/ Nf 7) and from a control subject (CTR- Nf 10). An antibody against 
 N. ﬂ avescens was used before permeabilization followed by a secondary Cy5-conjugated antibody and, after permeabilization, with an Alexaﬂ uor-546-con-
jugated secondary antibody (red). We used LAMP-1 and an Alexaﬂ uor-488 (green)-conjugated secondary antibody to detect endo/lysosomes. Merge and 
InSet images show colocalization of the bacteria with lysosomes (white arrows). Uninfected CaCo-2 cells (NO bacteria), stained with anti  N. meningitidis 
antibody and processed for immunoﬂ uorescence as the other samples, served as control of the procedure. Samples were analyzed by confocal microscopy 
with ×63 oil immersion objective. Bars = 10 μ m.
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quently, mass spectrometry revealed that  Nf was the major species 
among those present in the  Neisseria isolates from the gut micro-
biome of active CD patients but absent from the gut of controls. 
Other rele vant diff erences between the microbiomes of active CD 
controls (10%). We confi rmed the viability of the CD-associated 
 Neisseria identifi ed with next-generation sequencing by cultur-
ing 17 biopsies (9 from active CD subjects and 8 from controls) 
under selective conditions for aerobic  Neisseria growth. Subse-
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from  Neisseria ﬂ avescens ( Nf ), isolated from 5 active celiac patients (CD- Nf 1, 2, 3, 7, and 8), promoted the production of pro-inﬂ ammatory cytokines by 
dendritic cells (DCs). CD11c + DCs isolated from the spleens of C57B6 mice were cultured for 48 h in the presence of retinoic acid (RA) and transforming 
growth factor-β (TGF-β ) with ﬁ ltered  Nf lysates from three active CD patients ( a ). All three tested bacterial lysates promoted the production of interleukin 
(IL)-12p40 by murine DCs, whereas untreated (stars upon horizontal bars), lipopolysaccharide (LPS)-treated (stars), and  L GG-treated DCs did not ( b ). 
Human monocyte-derived DCs were cultured for 48 h in the presence of RA and TGF-β with ﬁ ltered  Nf lysates isolated from active CD patients ( c ). Tumor 
necrosis factor-α (TNF-α ) levels were higher in supernatants of human DCs treated with  Nf 1,  Nf 7, and  Nf 8 bacterial strains isolated from small intestinal 
biopsies of CD patients, and in those challenged with  Nf 10 isolated from a pharyngeal swab of a control subject ( d ), than in those treated with bacterial 
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levels were higher in supernatants of human DCs challenged with  Nf 1,2,3 ﬁ ltered lysates than in those treated with bacterial LPS (stars) used as a pro-
inﬂ ammatory positive control and in untreated (UN) cells (stars upon horizontal bars) ( e ). Dot plots represent values from three independent experiments. 
Each experiment was performed in duplicate. A two-way analysis of variance was performed to check for inter-group differences. * P <0.05, ** P <0.01, 
*** P <0.001, and **** P <0.0001. 
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patients and controls were the reduced levels of Actinobacteria and 
Firmicutes in the active CD microbiome. Notably, two cultivable 
bacteria belonging to the Firmicutes phylum ( Lactobacillus and 
 Bacillus cereus) , which are involved in gluten metabolism, were 
not found in the active CD microbiome. Low levels of  Lactobacilli 
are one of the most consistent fi ndings in both adults and children 
with active CD ( 16,18,21 ); however, the relevance of this informa-
tion is unclear. Th e fecal levels of Firmicutes ( Lactobacillus ) and 
Actinobacteria were recently reported to be lower in active CD 
patients than in healthy controls, and this result was associated 
with diff erences in gluten metabolism among the two groups of 
individuals ( 53 ).
 We next asked the following questions: (1) Are there genetic 
and/or phenotypic diff erences between CD- Nf and commensal 
control- Nf ?; and (2) If there is a diff erence, does that diff erence 
enable CD- Nf to promote an abnormal response in the intestinal 
epithelium? To address these questions, we used next-generation 
sequencing to sequence the whole  Nf genome of strains isolated 
from the gut of active CD patients (CD- Nf 1, CD- Nf 2, and CD- Nf 3) 
and from the oropharynx of a control subject (control- Nf ). Th en we 
compared these sequences to those of other pathogenic and com-
mensal  Nf genomes present in GenBank. Notably, all CD- Nf and 
 Nm genomes showed genetic diversity of the iron acquisition sys-
tems with respect to the control- Nf and the other tested commen-
sal  Nf. In fact, the CD- Nf genomes lacked the  hpuA/B and  tbpA/B 
genes but possessed the  hmbR gene. Th is fi nding was supported by 
an  in vitro test of iron uptake showing that CD- Nf and control- Nf 
acquired iron from diff erent sources. However, although the  hmbR 
gene has been widely associated with pathogenicity in  Nm ( 48–50 ), 
the signifi cance of its presence in our CD- Nf genomes remains to 
be further investigated. Notably, our data show that gene structure 
and function diff er between CD- Nf and control- Nf .
 To answer the second question, we explored the infl ammatory 
eff ect of CD- Nf because overgrowth of pathogenic bacteria could 
lead to aberrant activation of the immune system. Interestingly, 
 in vitro , all the  Nf strains isolated from 5 adults aff ected by active 
CD induced an infl ammatory phenotype in human and murine 
DCs, as shown also for other bacterial strains ( 44 ). In detail, 
IL-12p40 and TNF-α levels were higher in pure bacterial lysates 
from CD- Nf than in lysates stimulated with a control bacterium 
( L GG) or with LPS. Th ese fi ndings support the notion that  Nf may 
promote a pro-infl ammatory phenotype in DCs residing in the 
intestinal mucosa of celiac subjects and thus contribute to the CD 
immune response characterized by high levels of infl ammatory 
cytokines. Furthermore, interferon-γ , TNF-α , and IL-23 levels 
were higher in the culture supernatants of biopsies treated with 
CD- Nf than in untreated biopsies from controls. Th ese data sup-
port our hypothesis that  Nf contributes to promoting infl ammation 
in the small intestine. Whether this infl ammation precedes or fol-
lows the onset of full-blown CD remains, however, to be studied. It 
is feasible that the infl ammatory conditions occurring in the gut of 
CD patients may favor the colonization of  Nf strains thus promot-
ing the maintenance of a pro-infl ammatory immune response; on 
the other hand, under certain conditions (environmental factors, 
viral infections, genetic predisposing factors, etc.),  Nf colonization 
of the duodenal tract is favored, and this event could contribute to 
triggering CD development in genetically susceptible individuals.
 Beside modulating the immune response, the microbiota may 
also play a role in CD by degrading toxic gluten peptides, thereby 
aiding gluten detoxifi cation  in vivo ( 54 ). In this context, it is note-
worthy that members of the  Neisseria genus are poorly active against 
intact and toxic gliadin peptides ( 55 ). Moreover, CD- Nf could aff ect 
intracellular traffi  cking in two ways: (a) CD- Nf escape from lysoso-
mal degradation could trigger a stress pathway independent of the 
gliadin peptide pathways; (b) CD- Nf could interfere with the path-
way involving the toxic gliadin peptides by following the intracel-
lular pathway previously identifi ed in CaCo-2 cells ( 56 ). Both these 
hypotheses deserve further investigation. However, it remains to be 
established whether the CD-associated bacterial species contributes 
to the pathogenesis of the disease or whether it is a consequence of 
it. At present, the induction of infl ammatory responses in DCs and 
in  ex-vivo mucosal explant supports the fi rst possibility.
 In conclusion, marked dysbiosis and an abundance of a peculiar 
CD- Nf strain characterize the duodenal microbiome of active CD 
patients, which suggests that the CD-associated microbiota could 
contribute to the many infl ammatory signals in this disorder.
 Table 2 .  CD- Nf challenge a induces duodenal mucosa from control subjects to secrete pro-inﬂ ammatory cytokines in supernatants 
 Treatment  Levels of cytokines (pg/ml) measured in supernatants mean (s.e.m.) 
  IFN-γ  TNF-α  IL-6  IL-23  IL-17A  IL-17F  IL-12p70 
 No treatment  23.44 (9.34)  10.10 (0.48)  135.29 (72.08)  38.69 (8.86)  8.42 (5.98)  5.17 (4.18)  6.43 (1.22) 
 Challenge with CD- Nf 
(MOI 1:10) 
 59.23 (2.40)  14.83 (2.12)  253.34 (147.57)  50.39 (11.84)  11.16 (7.92)  7.12 (5.01)  10.61 (2.15) 
 Challenge with CD- Nf 
(MOI 1:50) 
 107.94 (2.34)  23.24 (2.49)  452.66 (19.74)  106.01 (3.68)  25.01 (3.80)  21.06 (14.15)  14.71 (2.43) 
 P value b  0.001  0.011  0.249  0.015  0.320  0.353  0.082 
 IFN-γ , interferon-γ ; IL-6, interleukin-6; TNF-α , tumor necrosis factor-α . 
 a Ex- vivo mucosal explants from three control subjects were treated for 6 h with CD- Nf at a multiplicity of infection (MOI) 1:10 and 1:50, and then levels of inﬂ ammatory 
cytokines were measured in supernatants of those treated with respect to untreated biopsies. Differences between mean levels were tested by the Friedman test with 
Bonferroni correction, and the  p value is reported under each column. 
 b Boldface type indicates statistically signiﬁ cant differences among groups ( P <0.05). 
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 Study Highlights
 WHAT IS CURRENT KNOWLEDGE 
 ✓  The gut microbiota has a role in the maintenance of 
healthy status. 
 ✓  Duodenal dysbiosis has been reported also in celiac disease. 
 ✓  Results about the role of the microbiome in celiac disease 
development are inconclusive. 
 WHAT IS NEW HERE 
 ✓  Next-generation sequencing characterization of duodenal-
associated microbiomes revealed increased levels of a 
 Neisseria ﬂ avescens strain in adult celiac patients. 
 ✓  This strain possesses peculiar features in hemoglobin-
related and iron-uptake genes. 
 ✓  This CD-associated strain induced inﬂ ammation in 
dendritic cells and  ex-vivo mucosal explants, suggesting 
that it may concur to amplify CD mucosal derangement. 
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